CHICAGO TRUST Co NA Purchases 2,000 Shares of Neogen Co. (NASDAQ:NEOG)

CHICAGO TRUST Co NA increased its position in Neogen Co. (NASDAQ:NEOG) by 19.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,498 shares of the company’s stock after acquiring an additional 2,000 shares during the quarter. CHICAGO TRUST Co NA’s holdings in Neogen were worth $108,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of NEOG. Blue Trust Inc. boosted its stake in Neogen by 196.7% during the fourth quarter. Blue Trust Inc. now owns 3,368 shares of the company’s stock valued at $41,000 after buying an additional 2,233 shares during the period. Values First Advisors Inc. boosted its position in shares of Neogen by 77.7% during the 4th quarter. Values First Advisors Inc. now owns 28,692 shares of the company’s stock valued at $348,000 after acquiring an additional 12,545 shares during the last quarter. Bank Pictet & Cie Europe AG boosted its position in shares of Neogen by 6.5% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 132,000 shares of the company’s stock valued at $1,602,000 after acquiring an additional 8,000 shares during the last quarter. Rhumbline Advisers lifted its position in Neogen by 0.7% during the fourth quarter. Rhumbline Advisers now owns 699,490 shares of the company’s stock valued at $8,492,000 after purchasing an additional 4,890 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D lifted its position in Neogen by 19.2% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 139,110 shares of the company’s stock valued at $1,689,000 after purchasing an additional 22,429 shares during the last quarter. 96.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on NEOG. Piper Sandler dropped their target price on shares of Neogen from $6.40 to $5.00 and set a “neutral” rating for the company in a research report on Tuesday, April 22nd. Guggenheim dropped their price target on Neogen from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, April 10th.

Neogen Stock Performance

NASDAQ:NEOG opened at $5.52 on Tuesday. The company has a market capitalization of $1.20 billion, a price-to-earnings ratio of -2.52 and a beta of 1.84. The company has a debt-to-equity ratio of 0.33, a current ratio of 3.77 and a quick ratio of 2.46. Neogen Co. has a 1-year low of $3.87 and a 1-year high of $18.58. The business has a 50 day moving average of $5.78 and a 200 day moving average of $9.29.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings data on Wednesday, April 9th. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). The business had revenue of $221.00 million during the quarter, compared to the consensus estimate of $225.27 million. Neogen had a positive return on equity of 2.89% and a negative net margin of 52.12%. The company’s revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.12 earnings per share. On average, sell-side analysts predict that Neogen Co. will post 0.38 earnings per share for the current fiscal year.

Insider Buying and Selling at Neogen

In related news, CAO John Patrick Moylan acquired 10,000 shares of the stock in a transaction on Thursday, April 10th. The stock was purchased at an average price of $5.07 per share, for a total transaction of $50,700.00. Following the completion of the transaction, the chief accounting officer now owns 10,000 shares of the company’s stock, valued at $50,700. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Amy M. Rocklin acquired 12,500 shares of the stock in a transaction on Wednesday, April 23rd. The stock was bought at an average price of $4.99 per share, with a total value of $62,375.00. Following the transaction, the insider now directly owns 36,287 shares of the company’s stock, valued at approximately $181,072.13. The trade was a 52.55% increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 83,500 shares of company stock worth $431,525 over the last three months. Company insiders own 1.13% of the company’s stock.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.